Strategies to reduce risk of heat induced illness during intermittent, high intensity activity in a tropical environment. Regular intermittent, high intensity physical activity (IHIA) affords protection against modern life-style diseases (type II diabetes, coronary heart disease and some cancers) but when conducted in the tropics, exposes persons to the risk of dehydration, heat cramps, hypotension, heat syncope, heat exhaustion and heat stroke. Australia has rapid population growth in the tropi ....Strategies to reduce risk of heat induced illness during intermittent, high intensity activity in a tropical environment. Regular intermittent, high intensity physical activity (IHIA) affords protection against modern life-style diseases (type II diabetes, coronary heart disease and some cancers) but when conducted in the tropics, exposes persons to the risk of dehydration, heat cramps, hypotension, heat syncope, heat exhaustion and heat stroke. Australia has rapid population growth in the tropics and key sporting fixtures have moved to the region. We have set up the research capability and must now move on a range of IHIA in sport, workplaces, armed and emergency services to provide strategies to reduce the risk of heat induced illness in a tropical environment.Read moreRead less
Development of Acid Degradable Polymeric Nanoparticles for Intracellular and Tumour Site Selective Delivery of Drugs. There is an enormous need to develop effective anticancer drug delivery systems to reduce the social and economic impact of cancer. One of the most critical problems in tumour treatment is the lack of selective toxicity of anticancer drugs against tumour tissues. Our multidisciplinary team will aim to develop a novel polymer based system for tumour site-selective delivery of anti ....Development of Acid Degradable Polymeric Nanoparticles for Intracellular and Tumour Site Selective Delivery of Drugs. There is an enormous need to develop effective anticancer drug delivery systems to reduce the social and economic impact of cancer. One of the most critical problems in tumour treatment is the lack of selective toxicity of anticancer drugs against tumour tissues. Our multidisciplinary team will aim to develop a novel polymer based system for tumour site-selective delivery of anticancer drugs. Development of such advanced drug delivery systems will significantly enhance Australia`s power in biotechnology. Development and/or formation of strategies to improve the health quality of Australians, is an important anticipated outcome of this innovative project.Read moreRead less
Development and Evaluation of Well-Defined Polymer-RNA Conjugates as Improved Therapeutics. Gene-based drugs offer an enormous potential to treat a wide range of diseases including, but not limited to, AIDS, hepatitis, and cancer. However, effective delivery of these drugs in body is needed to convert their therapeutic potential to clinically applicable treatments. Our multidisciplinary team will aim to develop novel, polymer-gene hybrid materials for efficient delivery of gene based therapeuti ....Development and Evaluation of Well-Defined Polymer-RNA Conjugates as Improved Therapeutics. Gene-based drugs offer an enormous potential to treat a wide range of diseases including, but not limited to, AIDS, hepatitis, and cancer. However, effective delivery of these drugs in body is needed to convert their therapeutic potential to clinically applicable treatments. Our multidisciplinary team will aim to develop novel, polymer-gene hybrid materials for efficient delivery of gene based therapeutics. Development of such advanced drug delivery systems will significantly enhance Australia`s power in biotechnology. Development and/or formation of new materials and strategies to improve the health quality of Australians, is an important anticipated outcome of this innovative project. Read moreRead less